Advertisement
Screener

AGENUS INC (AGEN) Material Contracts, 2010

AGENUS INC Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2010-12-14: Form 8-K; Exhibit 10.2; Description AMENDMENT NUMBER FOUR TO ANTIGENICS INC. DIRECTORS' DEFERRED COMPENSATION PLAN.
  • 2010-12-14: Form 8-K; Exhibit 10.1; Description FORM OF SUBSCRIPTION AGREEMENT.
  • 2010-11-03: Form 8-K; Exhibit 10.1; Description AMENDED AND RESTATED EXECUTIVE CHANGE-IN-CONTROL PLAN.
  • 2010-08-06: Form 10-Q; Exhibit 10.2; Description SUBLEASE AGREEMENT BY AND BETWEEN ANTIGENICS INC. AND CUBIST PHARMACEUTICALS.
FiledFormExhibitDescription
2010-12-148-K10.2AMENDMENT NUMBER FOUR TO ANTIGENICS INC. DIRECTORS' DEFERRED COMPENSATION PLAN
2010-12-148-K10.1FORM OF SUBSCRIPTION AGREEMENT
2010-11-038-K10.1AMENDED AND RESTATED EXECUTIVE CHANGE-IN-CONTROL PLAN
2010-08-0610-Q10.2SUBLEASE AGREEMENT BY AND BETWEEN ANTIGENICS INC. AND CUBIST PHARMACEUTICALS
2010-08-0610-Q10.1LANDLORD, SUBLESSOR AND SUBLESSEE AGREEMENT
2010-03-1510-K10.4.1CURRENT SCHEDULE INDENTIFYING THE DIRECTORS AND EXECUTIVE OFFICERS

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60